Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00299804 in Metastatic/Recurrent HNSCC
NCT01449201Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Oct 2011
- Primary completion
- Oct 2013
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dacomitinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Yonsei University. Started Oct 2011; status: completed.
02
Drugs
dacomitinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01449201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449201.